Mytipred DZ 6mg Oral Suspension
By Mytipred-DZ
Rx
30ml Oral Suspension in a Bottle

Composition
Deflazacort(6mg)

Manufacturer - Integral Lifesciences
377, SCF First floor Motor Market, Manimajra, Chandigarh, Haryana 160101

Expires on or after
November, 2025

liver
Mytipred DZ 6mg Oral Suspension is considered safe for patients with liver disease. It is not necessary to adjust the dosage of Mytipred DZ 6mg Oral Suspension for individuals with liver issues.

kidney
Mytipred DZ 6mg Oral Suspension is safe for patients with kidney disease. No dose adjustment is needed for this medication.

alcohol
It is unsafe to drink alcohol while taking Mytipred DZ 6mg Oral Suspension. Avoid consuming alcohol when using this medication. Caution is advised for pregnant women regarding the use of Mytipred DZ 6mg Oral Suspension.

driving
Mytipred DZ 6mg Oral Suspension generally does not impact driving ability.

pregnancy
Mytipred DZ 6mg Oral Suspension is considered unsafe during pregnancy. Animal studies have shown potential harm to the developing baby. It is important to consult your doctor as they will assess the benefits and risks before prescribing it to you.

breastfeeding
Caution Mytipred DZ 6mg Oral Suspension is likely unsafe during breastfeeding. Limited data suggests it may transfer to breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Gluco/mineralocorticoids, progestogins and derivatives |
Therapeutic Class | HORMONES |
Action Class | - |
₹68.5
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025